- Home
- NEOV vs TELA Comparison
NEOV vs TELA Comparison
Compare NEOV & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEOV
- TELA
- Stock Information
- Founded
- NEOV 2018
- TELA 2012
- Country
- NEOV United States
- TELA United States
- Employees
- NEOV N/A
- TELA N/A
- Industry
- NEOV Industrial Machinery/Components
- TELA Medical/Dental Instruments
- Sector
- NEOV Miscellaneous
- TELA Health Care
- Exchange
- NEOV Nasdaq
- TELA Nasdaq
- Market Cap
- NEOV 72.2M
- TELA 80.7M
- IPO Year
- NEOV N/A
- TELA 2019
- Fundamental
- Price
- NEOV $4.52
- TELA $2.01
- Analyst Decision
- NEOV Strong Buy
- TELA Strong Buy
- Analyst Count
- NEOV 1
- TELA 4
- Target Price
- NEOV $7.50
- TELA $6.00
- AVG Volume (30 Days)
- NEOV 197.3K
- TELA 73.4K
- Earning Date
- NEOV 05-09-2025
- TELA 08-11-2025
- Dividend Yield
- NEOV N/A
- TELA N/A
- EPS Growth
- NEOV N/A
- TELA N/A
- EPS
- NEOV N/A
- TELA N/A
- Revenue
- NEOV $4,255,136.00
- TELA $71,217,000.00
- Revenue This Year
- NEOV $208.50
- TELA $26.67
- Revenue Next Year
- NEOV $128.75
- TELA $22.63
- P/E Ratio
- NEOV N/A
- TELA N/A
- Revenue Growth
- NEOV 52.64
- TELA 12.78
- 52 Week Low
- NEOV $1.80
- TELA $0.86
- 52 Week High
- NEOV $6.11
- TELA $5.18
- Technical
- Relative Strength Index (RSI)
- NEOV 75.13
- TELA 58.96
- Support Level
- NEOV $3.10
- TELA $1.97
- Resistance Level
- NEOV $4.75
- TELA $2.20
- Average True Range (ATR)
- NEOV 0.35
- TELA 0.17
- MACD
- NEOV 0.14
- TELA -0.01
- Stochastic Oscillator
- NEOV 89.94
- TELA 66.67
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.
About TELA TELA Bio Inc.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.